Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Sell
1,791
-198
-10% -$22.9K 0.01% 381
2026
Q1
$238K Hold
1,989
0.01% 350
2025
Q4
$271K Hold
1,989
0.02% 340
2025
Q3
$293K Buy
1,989
+91
+5% +$12.6K 0.02% 332
2025
Q2
$246K Sell
1,898
-25
-1% -$3.03K 0.01% 349
2025
Q1
$230K Sell
1,923
-621
-24% -$77K 0.02% 346
2024
Q4
$295K Buy
2,544
+198
+8% +$25K 0.02% 307
2024
Q3
$317K Hold
2,346
0.02% 290
2024
Q2
$318K Hold
2,346
0.03% 271
2024
Q1
$303K Hold
2,346
0.02% 293
2023
Q4
$268K Buy
2,346
+35
+2% +$3.49K 0.02% 309
2023
Q3
$210K Hold
2,311
0.02% 332
2023
Q2
$260K Hold
2,311
0.02% 318
2023
Q1
$242K Buy
+2,311
New +$241K 0.03% 254

Other funds holding XYL

Courier Capital's XYL Position: Q2 2026 in Review

Courier Capital reduced its Xylem (XYL) stake by 10% in Q2 2026, selling an estimated $22.9K and leaving 1,791 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #381.

Courier Capital first reported a position in XYL in Q1 2023 and has held it in 14 quarters since. The position peaked at $318K in Q2 2024. 424 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Courier Capital held 1,791 shares of Xylem worth $212K as of Q2 2026.
  • Courier Capital sold 198 Xylem shares in Q2 2026, an estimated $22.9K.
  • Xylem made up 0.01% of Courier Capital's portfolio in Q2 2026, its #381 holding.
  • Courier Capital first reported a position in Xylem in Q1 2023 and has held it in 14 quarters since.
  • Courier Capital's Xylem position peaked at $318K in Q2 2024.
  • 424 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.